SCHEMBL21770951

SCHEMBL21770951

Cc1ccc(CN2CCN(C)c3cc(C)ncc3C2=O)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CACNA2D1 P54289 11/20 0.56
SLC6A2 P23975 7/20 0.56
HTT P42858 2/20 0.44
TP53 P04637 1/20 0.41
LMNA P02545 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
TDP1 Q9NUW8 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
TRPC5 Q9UL62 1/20 0.39
HDAC3 O15379 1/20 0.38
HDAC4 P56524 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC7 Q8WUI4 1/20 0.38
HDAC2 Q92769 1/20 0.38
HDAC10 Q969S8 1/20 0.38
HDAC11 Q96DB2 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19564861 0.81 CACNA2D1 (0.57) CACNA2D1SLC6A2HTTTP53LMNA
SCHEMBL21770358 0.78 CACNA2D1 (0.58) CACNA2D1SLC6A2HTT
SCHEMBL21770344 0.75 SLC6A2 (0.84) CACNA2D1SLC6A2
SCHEMBL19564688 0.75 SLC6A2 (0.84) CACNA2D1SLC6A2
SCHEMBL21770544 0.75 CACNA2D1 (0.60) CACNA2D1SLC6A2HTT
SCHEMBL21770687 0.74 CACNA2D1 (0.61) CACNA2D1SLC6A2
SCHEMBL19553469 0.74 SLC6A2 (1.00) CACNA2D1SLC6A2
SCHEMBL19553468 0.74 SLC6A2 (1.00) CACNA2D1SLC6A2
SCHEMBL21000214 0.72 CACNA2D1 (0.66) CACNA2D1SLC6A2
SCHEMBL21770859 0.72 CACNA2D1 (0.54) CACNA2D1SLC6A2HTTTP53LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3452475-B1 TETRAHYDROPYRIMIDODIAZEPINE AND TETRAHYDROPYRIDODIAZEPINE COMPOUNDS FOR TREATING PAIN AND PAIN RELATED CONDITIONS ESTEVE PHARMACEUTICALS SA (ES) 2020-02-26 EP disclosed